MDY Mdy Healthcare

RNS Number:1128S
Medical House PLC
5 October 2000


MEDICAL HOUSE PLC
Posting of Circular and Trading Update

On 2 October 2000 the Directors announced that the Company has been granted an
exclusive license by Hyperguard Ltd, a wholly owned subsidiary of Medisys plc,
for the world-wide rights to a method of detecting helicobactor pylori (a
bacteria responsible for several common gastric complaints) and that Medisys
plc have also agreed to subscribe for New Ordinary Shares in The Medical House
plc for a value of #1.75 million.  Further to that announcement, the
Directors are pleased to announce that a circular has been posted to
shareholders today.  The purpose of the circular is to convene an
extraordinary general meeting on 31 October 2000 at which a resolution will be
proposed to increase the Directors' authority to allott shares, thereby
enabling the balance of shares issuable to Medisys plc to be issued.

The Directors are also pleased to announce that further to the profit forecast
included in the Prospectus dated 28 June 2000 ("Prospectus"), the actual pre-
tax profits of the companies in The Medical House Group (at the time the
prospectus was issued) for year ended 30 June 2000 was #318,000.  This result
is some #18,000 greater than the profit forecast included in the Prospectus.

The Medical House PLC                            0114 261 9011
Ian Townsend, Chief Executive           www.themedicalhouse.com

Brewin Dolphin Securities Ltd                     0113 241 0130
Mark Brady/Andrew Emmott                www.brewindolphin.co.uk

Square Mile Communications                        020 7601 1000
Nick Oborne                                    info@sq-mile.com

MDY Healthcare (LSE:MDY)
Historical Stock Chart
Von Jun 2024 bis Jul 2024

MDY Healthcare (LSE:MDY)
Historical Stock Chart
Von Jul 2023 bis Jul 2024